Results for tag: "MMR II"

The MMR II market is a segment of the global vaccine market that focuses on the production and distribution of the MMR II vaccine. The MMR II vaccine is a combination vaccine that protects against three diseases: measles, mumps, and rubella. It is typically administered to children between the ages of 12 and 15 months, with a booster dose recommended between the ages of 4 and 6 years. The MMR II vaccine is widely used in many countries, and is considered to be one of the most effective vaccines available. The MMR II market is highly competitive, with many companies offering their own versions of the vaccine. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Other companies, such as CSL Limited, Serum Institute of India, and Bharat Biotech, also produce and distribute MMR II vaccines. Show Less Read more